Sale!

EIF2B1 Gene Leukoencephalopathy with vanishing white matter Genetic Test

4,400 د.إ

-21%

The EIF2B1 gene is associated with a rare neurological disorder known as Leukoencephalopathy with Vanishing White Matter (VWM). This condition is characterized by progressive deterioration of white matter in the brain, leading to symptoms such as motor dysfunction, spasticity, and in severe cases, premature death. The disorder is genetic in nature, inherited in an autosomal recessive pattern, meaning that two copies of the mutated gene, one from each parent, are required for an individual to be affected.

A genetic test for mutations in the EIF2B1 gene can confirm a diagnosis of VWM, providing crucial information for affected individuals and their families regarding prognosis, potential treatments, and genetic counseling. The test involves analyzing DNA, usually from a blood sample, to identify mutations in the EIF2B1 gene that are known to cause the disorder.

In the UAE, DNA Labs offers this specialized genetic testing for individuals suspected of having Leukoencephalopathy with Vanishing White Matter. The cost of the test is 4400 AED, which reflects the sophisticated technology and expertise required to accurately identify mutations in the EIF2B1 gene. This test is a vital resource for families seeking answers about this rare and challenging condition, offering a path towards a more informed approach to care and management.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

EIF2B1 Gene Leukoencephalopathy with vanishing white matter Genetic Test

At DNA Labs UAE, we offer the EIF2B1 Gene Leukoencephalopathy with vanishing white matter Genetic Test at a cost of AED 4400.0.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the EIF2B1 Gene Leukoencephalopathy with vanishing white matter NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with EIF2B1 Gene Leukoencephalopathy with vanishing white matter.

Test Details

The EIF2B1 gene is associated with a genetic disorder called Leukoencephalopathy with vanishing white matter (VWM). This disorder affects the white matter of the brain, leading to progressive neurological symptoms.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes. In the context of Leukoencephalopathy with vanishing white matter, NGS genetic testing can be used to identify mutations or variations in the EIF2B1 gene that may be causative or associated with the disorder.

By performing NGS genetic testing on an individual suspected of having VWM, healthcare professionals can determine if there are any pathogenic variants in the EIF2B1 gene. This information can help with diagnosis, prognosis, and potentially guide treatment decisions for the patient and their family members.

It is important to note that genetic testing for VWM should be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate genetic counseling and support.

Test Name EIF2B1 Gene Leukoencephalopathy with vanishing white matter Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for EIF2B1 Gene Leukoencephalopathy with vanishing white matter NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with EIF2B1 Gene Leukoencephalopathy with vanishing white matter
Test Details

The EIF2B1 gene is associated with a genetic disorder called Leukoencephalopathy with vanishing white matter (VWM). This disorder affects the white matter of the brain, leading to progressive neurological symptoms.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes. In the context of Leukoencephalopathy with vanishing white matter, NGS genetic testing can be used to identify mutations or variations in the EIF2B1 gene that may be causative or associated with the disorder.

By performing NGS genetic testing on an individual suspected of having VWM, healthcare professionals can determine if there are any pathogenic variants in the EIF2B1 gene. This information can help with diagnosis, prognosis, and potentially guide treatment decisions for the patient and their family members.

It is important to note that genetic testing for VWM should be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate genetic counseling and support.